世界の呼吸器疾患治療市場予測2023-2029：吸入＆点鼻薬、経口薬、その他

【英語タイトル】Human Respiratory Disease Treatment Market, Global Outlook and Forecast 2023-2029

・商品コード：MMG23LY8779
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：63
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の呼吸器疾患治療市場規模と予測を収録しています。・世界の呼吸器疾患治療市場：売上、2018年-2023年、2024年-2029年
・世界の呼吸器疾患治療市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の呼吸器疾患治療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「吸入＆点鼻薬」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

呼吸器疾患治療のグローバル主要企業は、GSK、 AstraZeneca、 Boehringer Ingelheim、 Vertex、 Roche、 Novartis、 Teva、 Chiesi、 Viatris、 Sumitomo Dainippon、 Merck、 Beximcoなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、呼吸器疾患治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の呼吸器疾患治療市場：タイプ別、2018年-2023年、2024年-2029年
世界の呼吸器疾患治療市場：タイプ別市場シェア、2022年
・吸入＆点鼻薬、経口薬、その他

世界の呼吸器疾患治療市場：用途別、2018年-2023年、2024年-2029年
世界の呼吸器疾患治療市場：用途別市場シェア、2022年
・病院、薬局、その他

世界の呼吸器疾患治療市場：地域・国別、2018年-2023年、2024年-2029年
世界の呼吸器疾患治療市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における呼吸器疾患治療のグローバル売上、2018年-2023年
・主要企業における呼吸器疾患治療のグローバル売上シェア、2022年
・主要企業における呼吸器疾患治療のグローバル販売量、2018年-2023年
・主要企業における呼吸器疾患治療のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
GSK、 AstraZeneca、 Boehringer Ingelheim、 Vertex、 Roche、 Novartis、 Teva、 Chiesi、 Viatris、 Sumitomo Dainippon、 Merck、 Beximco

*************************************************************

・調査・分析レポートの概要
呼吸器疾患治療市場の定義
市場セグメント
世界の呼吸器疾患治療市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の呼吸器疾患治療市場規模
世界の呼吸器疾患治療市場規模：2022年 VS 2029年
世界の呼吸器疾患治療市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの呼吸器疾患治療の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の呼吸器疾患治療製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：吸入＆点鼻薬、経口薬、その他
呼吸器疾患治療のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、薬局、その他
呼吸器疾患治療の用途別グローバル売上・予測

・地域別市場分析
地域別呼吸器疾患治療市場規模 2022年と2029年
地域別呼吸器疾患治療売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
GSK、 AstraZeneca、 Boehringer Ingelheim、 Vertex、 Roche、 Novartis、 Teva、 Chiesi、 Viatris、 Sumitomo Dainippon、 Merck、 Beximco
...

Respiratory drug is a term used to describe a wide variety of medicines used to relieve, treat, or prevent respiratory diseases such as asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), or pneumonia.
This report aims to provide a comprehensive presentation of the global market for Human Respiratory Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Respiratory Disease Treatment. This report contains market size and forecasts of Human Respiratory Disease Treatment in global, including the following market information:
Global Human Respiratory Disease Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Human Respiratory Disease Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Inhalable & Nasal Spray Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Human Respiratory Disease Treatment include GSK, AstraZeneca, Boehringer Ingelheim, Vertex, Roche, Novartis, Teva, Chiesi and Viatris, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Respiratory Disease Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Respiratory Disease Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Human Respiratory Disease Treatment Market Segment Percentages, by Type, 2022 (%)
Inhalable & Nasal Spray
Oral
Others
Global Human Respiratory Disease Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Human Respiratory Disease Treatment Market Segment Percentages, by Application, 2022 (%)
Hospital
Retail Pharmacy
Others
Global Human Respiratory Disease Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Human Respiratory Disease Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Respiratory Disease Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Human Respiratory Disease Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
AstraZeneca
Boehringer Ingelheim
Vertex
Roche
Novartis
Teva
Chiesi
Viatris
Sumitomo Dainippon
Merck
Beximco
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Respiratory Disease Treatment, market overview.
Chapter 2: Global Human Respiratory Disease Treatment market size in revenue.
Chapter 3: Detailed analysis of Human Respiratory Disease Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Respiratory Disease Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Human Respiratory Disease Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Respiratory Disease Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Respiratory Disease Treatment Overall Market Size
2.1 Global Human Respiratory Disease Treatment Market Size: 2022 VS 2029
2.2 Global Human Respiratory Disease Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Human Respiratory Disease Treatment Players in Global Market
3.2 Top Global Human Respiratory Disease Treatment Companies Ranked by Revenue
3.3 Global Human Respiratory Disease Treatment Revenue by Companies
3.4 Top 3 and Top 5 Human Respiratory Disease Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Human Respiratory Disease Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Human Respiratory Disease Treatment Players in Global Market
3.6.1 List of Global Tier 1 Human Respiratory Disease Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Human Respiratory Disease Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Human Respiratory Disease Treatment Market Size Markets, 2022 & 2029
4.1.2 Inhalable & Nasal Spray
4.1.3 Oral
4.1.4 Others
4.2 By Type – Global Human Respiratory Disease Treatment Revenue & Forecasts
4.2.1 By Type – Global Human Respiratory Disease Treatment Revenue, 2018-2023
4.2.2 By Type – Global Human Respiratory Disease Treatment Revenue, 2024-2029
4.2.3 By Type – Global Human Respiratory Disease Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Human Respiratory Disease Treatment Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Others
5.2 By Application – Global Human Respiratory Disease Treatment Revenue & Forecasts
5.2.1 By Application – Global Human Respiratory Disease Treatment Revenue, 2018-2023
5.2.2 By Application – Global Human Respiratory Disease Treatment Revenue, 2024-2029
5.2.3 By Application – Global Human Respiratory Disease Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Human Respiratory Disease Treatment Market Size, 2022 & 2029
6.2 By Region – Global Human Respiratory Disease Treatment Revenue & Forecasts
6.2.1 By Region – Global Human Respiratory Disease Treatment Revenue, 2018-2023
6.2.2 By Region – Global Human Respiratory Disease Treatment Revenue, 2024-2029
6.2.3 By Region – Global Human Respiratory Disease Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Human Respiratory Disease Treatment Revenue, 2018-2029
6.3.2 US Human Respiratory Disease Treatment Market Size, 2018-2029
6.3.3 Canada Human Respiratory Disease Treatment Market Size, 2018-2029
6.3.4 Mexico Human Respiratory Disease Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Human Respiratory Disease Treatment Revenue, 2018-2029
6.4.2 Germany Human Respiratory Disease Treatment Market Size, 2018-2029
6.4.3 France Human Respiratory Disease Treatment Market Size, 2018-2029
6.4.4 U.K. Human Respiratory Disease Treatment Market Size, 2018-2029
6.4.5 Italy Human Respiratory Disease Treatment Market Size, 2018-2029
6.4.6 Russia Human Respiratory Disease Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Human Respiratory Disease Treatment Market Size, 2018-2029
6.4.8 Benelux Human Respiratory Disease Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Human Respiratory Disease Treatment Revenue, 2018-2029
6.5.2 China Human Respiratory Disease Treatment Market Size, 2018-2029
6.5.3 Japan Human Respiratory Disease Treatment Market Size, 2018-2029
6.5.4 South Korea Human Respiratory Disease Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Human Respiratory Disease Treatment Market Size, 2018-2029
6.5.6 India Human Respiratory Disease Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Human Respiratory Disease Treatment Revenue, 2018-2029
6.6.2 Brazil Human Respiratory Disease Treatment Market Size, 2018-2029
6.6.3 Argentina Human Respiratory Disease Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Human Respiratory Disease Treatment Revenue, 2018-2029
6.7.2 Turkey Human Respiratory Disease Treatment Market Size, 2018-2029
6.7.3 Israel Human Respiratory Disease Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Human Respiratory Disease Treatment Market Size, 2018-2029
6.7.5 UAE Human Respiratory Disease Treatment Market Size, 2018-2029
7 Human Respiratory Disease Treatment Companies Profiles
7.1 GSK
7.1.1 GSK Company Summary
7.1.2 GSK Business Overview
7.1.3 GSK Human Respiratory Disease Treatment Major Product Offerings
7.1.4 GSK Human Respiratory Disease Treatment Revenue in Global Market (2018-2023)
7.1.5 GSK Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Company Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Human Respiratory Disease Treatment Major Product Offerings
7.2.4 AstraZeneca Human Respiratory Disease Treatment Revenue in Global Market (2018-2023)
7.2.5 AstraZeneca Key News & Latest Developments
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Company Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Human Respiratory Disease Treatment Major Product Offerings
7.3.4 Boehringer Ingelheim Human Respiratory Disease Treatment Revenue in Global Market (2018-2023)
7.3.5 Boehringer Ingelheim Key News & Latest Developments
7.4 Vertex
7.4.1 Vertex Company Summary
7.4.2 Vertex Business Overview
7.4.3 Vertex Human Respiratory Disease Treatment Major Product Offerings
7.4.4 Vertex Human Respiratory Disease Treatment Revenue in Global Market (2018-2023)
7.4.5 Vertex Key News & Latest Developments
7.5 Roche
7.5.1 Roche Company Summary
7.5.2 Roche Business Overview
7.5.3 Roche Human Respiratory Disease Treatment Major Product Offerings
7.5.4 Roche Human Respiratory Disease Treatment Revenue in Global Market (2018-2023)
7.5.5 Roche Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Human Respiratory Disease Treatment Major Product Offerings
7.6.4 Novartis Human Respiratory Disease Treatment Revenue in Global Market (2018-2023)
7.6.5 Novartis Key News & Latest Developments
7.7 Teva
7.7.1 Teva Company Summary
7.7.2 Teva Business Overview
7.7.3 Teva Human Respiratory Disease Treatment Major Product Offerings
7.7.4 Teva Human Respiratory Disease Treatment Revenue in Global Market (2018-2023)
7.7.5 Teva Key News & Latest Developments
7.8 Chiesi
7.8.1 Chiesi Company Summary
7.8.2 Chiesi Business Overview
7.8.3 Chiesi Human Respiratory Disease Treatment Major Product Offerings
7.8.4 Chiesi Human Respiratory Disease Treatment Revenue in Global Market (2018-2023)
7.8.5 Chiesi Key News & Latest Developments
7.9 Viatris
7.9.1 Viatris Company Summary
7.9.2 Viatris Business Overview
7.9.3 Viatris Human Respiratory Disease Treatment Major Product Offerings
7.9.4 Viatris Human Respiratory Disease Treatment Revenue in Global Market (2018-2023)
7.9.5 Viatris Key News & Latest Developments
7.10 Sumitomo Dainippon
7.10.1 Sumitomo Dainippon Company Summary
7.10.2 Sumitomo Dainippon Business Overview
7.10.3 Sumitomo Dainippon Human Respiratory Disease Treatment Major Product Offerings
7.10.4 Sumitomo Dainippon Human Respiratory Disease Treatment Revenue in Global Market (2018-2023)
7.10.5 Sumitomo Dainippon Key News & Latest Developments
7.11 Merck
7.11.1 Merck Company Summary
7.11.2 Merck Business Overview
7.11.3 Merck Human Respiratory Disease Treatment Major Product Offerings
7.11.4 Merck Human Respiratory Disease Treatment Revenue in Global Market (2018-2023)
7.11.5 Merck Key News & Latest Developments
7.12 Beximco
7.12.1 Beximco Company Summary
7.12.2 Beximco Business Overview
7.12.3 Beximco Human Respiratory Disease Treatment Major Product Offerings
7.12.4 Beximco Human Respiratory Disease Treatment Revenue in Global Market (2018-2023)
7.12.5 Beximco Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Human Respiratory Disease Treatment Market Opportunities & Trends in Global Market
Table 2. Human Respiratory Disease Treatment Market Drivers in Global Market
Table 3. Human Respiratory Disease Treatment Market Restraints in Global Market
Table 4. Key Players of Human Respiratory Disease Treatment in Global Market
Table 5. Top Human Respiratory Disease Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Human Respiratory Disease Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Human Respiratory Disease Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Human Respiratory Disease Treatment Product Type
Table 9. List of Global Tier 1 Human Respiratory Disease Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Respiratory Disease Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Human Respiratory Disease Treatment Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Human Respiratory Disease Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Human Respiratory Disease Treatment Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Human Respiratory Disease Treatment Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Human Respiratory Disease Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Human Respiratory Disease Treatment Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Human Respiratory Disease Treatment Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Human Respiratory Disease Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Human Respiratory Disease Treatment Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Human Respiratory Disease Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Human Respiratory Disease Treatment Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Human Respiratory Disease Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Human Respiratory Disease Treatment Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Human Respiratory Disease Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Human Respiratory Disease Treatment Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Human Respiratory Disease Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Human Respiratory Disease Treatment Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Human Respiratory Disease Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Human Respiratory Disease Treatment Revenue, (US$, Mn), 2024-2029
Table 30. GSK Company Summary
Table 31. GSK Human Respiratory Disease Treatment Product Offerings
Table 32. GSK Human Respiratory Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. GSK Key News & Latest Developments
Table 34. AstraZeneca Company Summary
Table 35. AstraZeneca Human Respiratory Disease Treatment Product Offerings
Table 36. AstraZeneca Human Respiratory Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. AstraZeneca Key News & Latest Developments
Table 38. Boehringer Ingelheim Company Summary
Table 39. Boehringer Ingelheim Human Respiratory Disease Treatment Product Offerings
Table 40. Boehringer Ingelheim Human Respiratory Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Boehringer Ingelheim Key News & Latest Developments
Table 42. Vertex Company Summary
Table 43. Vertex Human Respiratory Disease Treatment Product Offerings
Table 44. Vertex Human Respiratory Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Vertex Key News & Latest Developments
Table 46. Roche Company Summary
Table 47. Roche Human Respiratory Disease Treatment Product Offerings
Table 48. Roche Human Respiratory Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Roche Key News & Latest Developments
Table 50. Novartis Company Summary
Table 51. Novartis Human Respiratory Disease Treatment Product Offerings
Table 52. Novartis Human Respiratory Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. Novartis Key News & Latest Developments
Table 54. Teva Company Summary
Table 55. Teva Human Respiratory Disease Treatment Product Offerings
Table 56. Teva Human Respiratory Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. Teva Key News & Latest Developments
Table 58. Chiesi Company Summary
Table 59. Chiesi Human Respiratory Disease Treatment Product Offerings
Table 60. Chiesi Human Respiratory Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. Chiesi Key News & Latest Developments
Table 62. Viatris Company Summary
Table 63. Viatris Human Respiratory Disease Treatment Product Offerings
Table 64. Viatris Human Respiratory Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 65. Viatris Key News & Latest Developments
Table 66. Sumitomo Dainippon Company Summary
Table 67. Sumitomo Dainippon Human Respiratory Disease Treatment Product Offerings
Table 68. Sumitomo Dainippon Human Respiratory Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 69. Sumitomo Dainippon Key News & Latest Developments
Table 70. Merck Company Summary
Table 71. Merck Human Respiratory Disease Treatment Product Offerings
Table 72. Merck Human Respiratory Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 73. Merck Key News & Latest Developments
Table 74. Beximco Company Summary
Table 75. Beximco Human Respiratory Disease Treatment Product Offerings
Table 76. Beximco Human Respiratory Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 77. Beximco Key News & Latest Developments
List of Figures
Figure 1. Human Respiratory Disease Treatment Segment by Type in 2022
Figure 2. Human Respiratory Disease Treatment Segment by Application in 2022
Figure 3. Global Human Respiratory Disease Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Human Respiratory Disease Treatment Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Human Respiratory Disease Treatment Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Human Respiratory Disease Treatment Revenue in 2022
Figure 8. By Type - Global Human Respiratory Disease Treatment Revenue Market Share, 2018-2029
Figure 9. By Application - Global Human Respiratory Disease Treatment Revenue Market Share, 2018-2029
Figure 10. By Type - Global Human Respiratory Disease Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Human Respiratory Disease Treatment Revenue Market Share, 2018-2029
Figure 12. By Application - Global Human Respiratory Disease Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Human Respiratory Disease Treatment Revenue Market Share, 2018-2029
Figure 14. By Region - Global Human Respiratory Disease Treatment Revenue Market Share, 2018-2029
Figure 15. By Country - North America Human Respiratory Disease Treatment Revenue Market Share, 2018-2029
Figure 16. US Human Respiratory Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Human Respiratory Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Human Respiratory Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Human Respiratory Disease Treatment Revenue Market Share, 2018-2029
Figure 20. Germany Human Respiratory Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 21. France Human Respiratory Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Human Respiratory Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Human Respiratory Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Human Respiratory Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Human Respiratory Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Human Respiratory Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Human Respiratory Disease Treatment Revenue Market Share, 2018-2029
Figure 28. China Human Respiratory Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Human Respiratory Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Human Respiratory Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Human Respiratory Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 32. India Human Respiratory Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Human Respiratory Disease Treatment Revenue Market Share, 2018-2029
Figure 34. Brazil Human Respiratory Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Human Respiratory Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Human Respiratory Disease Treatment Revenue Market Share, 2018-2029
Figure 37. Turkey Human Respiratory Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Human Respiratory Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Human Respiratory Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Human Respiratory Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 41. GSK Human Respiratory Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. AstraZeneca Human Respiratory Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Boehringer Ingelheim Human Respiratory Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Vertex Human Respiratory Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Roche Human Respiratory Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Novartis Human Respiratory Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Teva Human Respiratory Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Chiesi Human Respiratory Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Viatris Human Respiratory Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Sumitomo Dainippon Human Respiratory Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Merck Human Respiratory Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Beximco Human Respiratory Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

★調査レポート[世界の呼吸器疾患治療市場予測2023-2029：吸入＆点鼻薬、経口薬、その他] (コード：MMG23LY8779)販売に関する免責事項を必ずご確認ください。

★調査レポート[世界の呼吸器疾患治療市場予測2023-2029：吸入＆点鼻薬、経口薬、その他]についてメールでお問い合わせ

MarketReport.jp

世界の呼吸器疾患治療市場予測2023-2029：吸入＆点鼻薬、経口薬、その他

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料 総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp